I support biopharma teams in accelerating process development, reducing costs, and improving outcomes by combining bioprocess expertise with AI-powered modeling and digital twins. During our consultation, we can focus on topics such as: • AI-driven Design of Experiments (DoE) to optimize lab runs and save time • Digital twins for upstream processes (mAbs, CHO cells, CGT, viral vectors) • Cell culture & bioreactor optimization with actionable parameter insights • Critical Process Parameters (CPP) & Critical Quality Attributes (CQA) modeling • Regulatory alignment (ICH Q8–Q12, FDA credibility frameworks) • Strategic guidance on Horizon Europe funding, partnerships, and biotech scaling This session is ideal for R&D leaders, CMC teams, and biotech founders who want clear, science-grounded, and actionable insights on how to adopt AI in bioprocessing.

Location

DEU